Citigroup analyst Jason Bazinet maintains Outfront Media (NYSE:OUT) with a Buy and lowers the price target from $30 to $28.
Needham Reiterates Buy on Alnylam Pharmaceuticals, Maintains $240 Price Target
Needham analyst Joseph Stringer reiterates Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and maintains $240 price target.